Goldline Pharmaceutical - News
BSE: 544759
₹32.65
As on 30-Sep-2026 13:56IST
Market cap
₹32 Cr
Revenue (TTM)
₹31 Cr
P/E Ratio
7.8
P/B Ratio
1.3
Div. Yield
0 %
Annual Reports
Announcements
View AnnouncementsIntimation Of Record Date For Remote E-Voting
06-Aug-2026No News & Announcements are available.